ArticleJournal of neurological surgery. Part B, Skull base2026
Geographic Trends and Disparities in Meningioma Mortality: A National Observational Study from 1999 to 2020 Utilizing the CDC Wonder Database.
Article in Journal of neurological surgery. Part B, Skull base, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Somatostatin receptor PET in meningioma: diagnosis, therapy, and surveillance.Nuclear medicine communications · 2026Review
- Trends in meningioma-related mortality among U.S. adults: A CDC WONDER analysis from 2000 to 2023.Surgical neurology international · 2026Article
- Somatostatin receptor PET-guided treatment and artificial intelligence applications in meningioma: a comprehensive review.American journal of nuclear medicine and molecular imaging · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Meningiomas are benign tumors that surround the brain and spinal cord. While studies have examined disparities in meningioma outcomes nationally, the meningioma mortality rate based on urbanization level is unclear. This study utilized the Centers for Disease Control Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) database to investigate meningioma mortality rates and disparities between urbanization categories. Methods: Patients whose underlying cause of death was meningioma from 1999 to 2020 were included. Chi-squared testing determined mortality differences across urbanization groups (large central metro, large fringe metro, and medium metro). Multivariable logistic regression and adjusted odds ratios (OR) evaluated associations between death location and age, sex, race, and ethnicity. Age-adjusted meningioma mortality rates per 100,000 people with 95% confidence intervals (CIs) were reported. Results: We analyzed a cohort of 12,274 patients. All older age groups demonstrated significantly lower odds of mortality in large central metros compared with other regions (OR: 0.54-0.69; Conclusion: We report that urbanization plays a significant role in meningioma mortality, with varying effects by sex, race, ethnicity, and age.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.